normative
Insulin Makers Won't Buy CGMs; Value Follows Data
Insulin manufacturers are not interested in buying CGM makers because they are pharmaceutical businesses, and Dexcom is staying in its lane because value accrues to whoever captures patient glucose data first.
normativepending
Speaker
AnealEvidence Quote
“I think they realize that the value actually accrues to the party that gets the patient data.”
Created: 11/20/2026, 5:18:27 AM
Your notes
Loading notes...